Animesh D. Pardanani, MBBS, PhD¹, Jason Gotlib, MD, MS^2*, Catriona Jamieson, MD, PhD³, Jorge Cortes, MD⁴, Moshe Talpaz, MD^5*, Richard M. Stone, MD⁶, Michael H Silverman, MD, FACP^7*, Jolene Shorr^8*, D. Gary Gilliland⁹ and Ayalew Tefferi, MD¹⁰

¹Mayo Clinic, Rochester, MN
²Stanford University School of Medicine, Stanford, CA
³Deapartment of Medicine and Moores Cancer Center, University of California San Diego, La Jolla, CA
⁴M.D. Anderson Cancer Center, Houston, TX
⁵Comprehensive Cancer Ctr., Univ. of Michigan, Ann Arbor, MI
⁶Dana-Farber Cancer Institute, Boston, MA
⁷Biostrategics Consulting Ltd., Marblehead, MA
⁸TargeGen Inc., San Diego, CA
⁹Brigham and Women's Hospital, Boston, MA
¹⁰Medicine, Division of Hematology, Mayo Clinic Graduate School of Medicine, Rochester, MN

Neil P. Shah, MD, PhD¹, Patrycja Olszynski^1*, Lubomir Sokol, MD, PhD², Srdan Verstovsek³, Ronald Hoffman, MD⁴, Alan F. List, MD⁵, Jorge Cortes, MD³, Hagop M Kantarjian⁶, D. Gary Gilliland⁷, Douglas O Clary, PhD^8*, Lynne A. Bui, MD⁸ and Martha Wadleigh, MD⁹

¹University of California - San Francisco, San Francisco, CA
²H. Lee Moffitt Cancer Center, Tampa, FL
³M.D. Anderson Cancer Center, Houston, TX
⁴Hematology, Mount Sinai School of Medicine, New York, NY
⁵H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶The University of Texas M. D. Anderson Cancer Center, Houston, TX
⁷Brigham and Women's Hospital, Boston, MA
⁸Exelixis, Inc., South San Francisco, CA
⁹Dana-Farber Cancer Inst., Boston, MA

Alison R Moliterno, MD¹, Gail J. Roboz, MD², Martin Carroll^3*, Selina Luger, MD⁴, Elizabeth Hexner, MD⁵ and Debra M. Bensen-Kennedy, MD⁶

¹Medicine, Johns Hopkins University School of Medicince, Baltimore, MD
²Medicine, Weill Cornell Medical College, New York, NY
³Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
⁴Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵University of Pennsylvania, Philadelphia, PA
⁶Cephalon, Frazer, PA

Alessandro Rambaldi¹, Chiara Maria Dellacasa^2*, Silvia Salmoiraghi^2*, Orietta Spinelli^2*, Maria Luisa Ferrari^2*, Elisabetta Gattoni, MD^3*, Paola Guglielmelli^4*, Alessandro M. Vannucchi⁴, Giovanni Barosi^5* and Tiziano Barbui^2*

¹Clinical Hematology Division, Hospital de Sant Pau, Barcelona, Spain
²USC Hematology, Ospedali Riuniti di Bergamo, Bergamo, Italy
³Laboratorio Epidemiologia Clinica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁴Hematology, Universitą  degli Studi di Firenze, Firenze, Italy
⁵Unit of Clinical Epidemiology, Center for the Study of Myelofibrosis, Istituto Policlinico San Matteo, Pavia, Italy

Xiaoli Wang, MD, PhD, Wei Zhang^*, Takefumi Ishii^*, Selcuk Sozer^*, Jiapeng Wang^*, Mingjiang Xu^* and Ronald Hoffman, MD^*

Division of Hematology/Oncology, Mount Sinai Cancer Institute, Departments of Medicine and Cell & Gene Medicine, Mount Sinai School of Medicine, New York, NY

Agostino Tafuri, MD¹, Francesca Pedini^2*, Federica Francescangeli^2*, Michele Signore^2*, Robert Foa³, Gabriella Girelli^4*, De Maria Ruggero^2* and Zeuner Ann^2*

¹Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome, Rome, Italy
²Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanitą, Roma, Italy
³Dept. of Cellular Biotechnologies & Hematology, University 'Sapienza', Rome, Italy
⁴Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome,, Roma, Italy